Cary Street Partners Asset Management LLC Amgen Inc Transaction History

Cary Street Partners Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $14,199 - $18,042	-62 Reduced 89.86%	7 $1,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $15,487 - $17,467	69 New	69 $15,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $4.55 Million - $5.05 Million	-19,483 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $327,761 - $381,952	1,477 Added 8.2%	19,483 $223,000
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $3.9 Million - $4.64 Million	18,006 New	18,006 $192,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cary Street Partners Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cary Street Partners Asset Management LLC with notifications on news.